Finance Times Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Finance Times Gazette.

Press releases published on October 2, 2026

Oct. 2, 2026

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

Indeterminate GlobeNewswire

Oct. 2, 2026

Teknisa Joins Volaris Group

Indeterminate GlobeNewswire

Oct. 2, 2026

Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization

Indeterminate GlobeNewswire

Oct. 2, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Thunder Bridge Capital Partners V, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 5, 2026

Indeterminate GlobeNewswire

Oct. 2, 2026

Arowana recertifies as a Certified B Corporation under B Lab's new global standards

Indeterminate GlobeNewswire

Oct. 2, 2026

Crypto News: Remittix Opens PayFi Testing to 1,000 Users as Bitcoin Price Prediction Eyes $100,000 and Litecoin Hits Eight-Month High

Indeterminate GlobeNewswire

Oct. 2, 2026

NN, Inc. Announces $50 Million Net Private Placement of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Oct. 2, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

HireQuotient’s EasySource Elevated to Featured Listing on Paylocity Marketplace Within a Month of Launching

Indeterminate GlobeNewswire

Oct. 2, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Aura Minerals Announces Mining Fleet Insourcing at Apoena, Almas and Borborema

Indeterminate GlobeNewswire

Oct. 2, 2026

Published Human Research Gives Family Caregivers a Way to Evaluate Joint Supplements

Indeterminate GlobeNewswire

Oct. 2, 2026

Alta Equipment Group Announces Preferred Stock Dividend

Indeterminate GlobeNewswire

Oct. 2, 2026

Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week

Indeterminate GlobeNewswire

Oct. 2, 2026

CECO Environmental to Transfer U.S. Stock Exchange Listing to the Texas Stock Exchange

Indeterminate GlobeNewswire

Oct. 2, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering

Indeterminate GlobeNewswire

Oct. 2, 2026

Plexrum Protocol Deploys Sepolia Testnet Prototype for Real Estate Record and Token Workflow Testing

Indeterminate GlobeNewswire

Oct. 2, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire